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Abstract	  
	  
Introduction:	  Gliofibromas	  are	  rare	  biphasic	  tumours	  with	  a	  good	  prognosis	  that	  usually	  occur	  in	  
childhood.	  Rare	  adult	  spinal	  cases	  have	  been	  treated	  with	  radiotherapy.	  This	  report	  descibes	  the	  
case	  of	  a	  gliofibroma	  occurring	  in	  a	  young	  adult	  10	  years	  after	  a	  treatment	  for	  a	  childhood	  pilocytic	  
astrocytoma.	  
Case:	   A	   14	   year	   old	   female	   underwent	   complete	   resection	   of	   a	   right	   lateral	   ventricle	   pilocytic	  
astrocytoma	   confirmed	   on	   post-­‐operative	   magnetic	   resonance	   imaging	   (MRI).	   At	   age	   17,	   the	  
tumour	  recurred	  and	  a	  second	  complete	  resection	  was	  performed.	  Due	  to	  the	  early	  recurrence	  she	  
was	   placed	   on	   long-­‐term	  MRI	   surveillance.	   	   At	   age	   23,	   an	   enhancing	   left	  midbrain	   tumour	  was	  
identified	  that	  was	  suspected	  to	  be	  a	  recurrent	  pilocytic	  astrocytoma.	  Following	  surgical	  resection	  
the	  histopathology	  revealed	  a	  gliofibroma.	  Due	  to	  the	  growth	  of	  further	  tumour	  nodules	  she	  was	  
treated	  with	  fractionated	  radiotherapy.	  	  There	  is	  no	  disease	  recurrence	  after	  36	  months	  follow-­‐up	  
and	  the	  patient	  remains	  well.	  
Discussion:	  Gliofibromas	  are	  tumours	  which	  usually	  occur	  in	  childhood,	  this	  case	  report	  identifies	  
a	   rare	   occurrence	   in	   an	   adult.	   The	   childhood	   intraventricular	   pilocytic	   astrocytoma	   was	   in	   an	  
anatomically	   distinct	   location	   to	   the	   midbrain	   gliofibroma.	   Radiotherapy	   can	   control	   these	  
tumours	  and	  follow	  up	  is	  required	  to	  undertand	  the	  long-­‐term	  outcome	  and	  prognosis.	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Introduction	  
Gliofibroma	  is	  a	  rare	  biphasic	  tumour	  [1].	  The	  majority	  occur	  as	  new	  tumours	  in	  childhood,	  with	  a	  
favourable	   post-­‐operative	   prognosis.	   Rarely	   these	   tumours	   occur	   in	   the	   spine	   in	   adults	   [2]	   and	  
require	  treatment	  with	  radiotherapy.	  In	  this	  report	  we	  describe	  the	  case	  of	  a	  cranial	  gliofibroma	  in	  
a	  young	  adult,	  that	  occurred	  6	  years	  after	  treatment	  of	  an	  intraventricular	  pilocytic	  astrocytoma.	  
	  
Case	  Report	  
A	   14	   year	   old	   female	   underwent	   gross	   total	   resection	   of	   a	   right	   lateral	   ventricle	   pilocytic	  
astrocytoma	   that	  was	   confirmed	  on	   the	  post-­‐operative	  magnetic	   resonance	   imaging	   (MRI)	   (figs.	  
1a-­‐b).	  Routine	  surveillance	  MRI	  revealed	  tumour	  recurrence	  and	  she	  underwent	  further	  surgery	  at	  
the	   age	   of	   17	   years.	   	   Complete	   resection	   was	   confirmed	   on	   the	   post-­‐operative	   MRI	   and	  
histopathology	  revealed	  a	  recurrent	  pilocytic	  astrocytoma.	  	  At	  age	  23,	  a	  surveillance	  MRI	  revealed	  
a	  small	  enhancing	  nodule	  in	  the	  left	  midbrain.	  The	  lesion	  was	  slightly	  hypointense	  on	  T1	  (fig.	  1c)	  
and	   hyperintense	   on	   T2	   weighted	   images	   (fig.	   1d)	   with	   strong	   contrast	   enhancement	   (fig.	   1e).	  
Another	   pilocytic	   astrocytoma	   was	   suspected.	   In	   March	   2011,	   a	   supracerebellar,	   infratentorial	  
approach	   was	   performed.	   A	   greyish	   tumour	   with	   a	   good	   plane	   around	   the	   brainstem	   in	   the	  
inferioromedial	   aspect	   was	   seen,	   with	   thick	   arachnoid	   superiorly	   and	   the	   tumour	  merging	   into	  
fibrous	   looking	   tissue.	   A	   subtotal	   resection	  was	   performed	   and	   post	   operatively,	   she	   recovered	  
well	  with	  no	  deficits.	  	  MRI	  confirmed	  a	  rim	  of	  enhancing	  residual	  tissue.	  
	  
The	   histology	   (fig.	   2a)	   showed	   strands	   of	   collagenous	   tissue	  with	   intervening	   thin	   trabeculae	   of	  
GFAP	   and	   synaptophysin	   positive	   material.	   The	   overall	   appearance	   was	   reactive	   and	   did	   not	  
correlate	  with	   her	   previous	   pathology.	   In	   the	   absence	   of	   confirmed	   tumour	   she	  was	   placed	   on	  
active	  MRI	  surveillance,	  but	  after	  3	  months	  the	  midbrain	  lesion	  progressed	  (fig.	  1f)	  and	  in	  January	  
2012	  she	  underwent	  a	  second	  resection.	  The	  histology	  (figs.	  2c-­‐f)	  showed	  a	  biphasic,	  moderately	  
cellular	  neoplasm	  comprising	  both	  a	  glial	   (GFAP	  positive,	   fig.	  2d)	  and	  a	   stromal	  component.	  The	  
cells	  were	  fibrillary,	  occasionally	  epithelioid	  or	  clear	  shaped	  arranged	  in	  fascicles	  and	  nests	  within	  
a	   dense	   reticulin	   positive	   stroma.	  Mitoses,	   necrosis	   and	   endothelial	   hyperpalsia	  were	   absent.	   A	  
few	  fat	  cells	  were	  present	  consistent	  with	  adipose	  metapalsia	  (figs.	  2b,e,f).	  Immunohistochemistry	  
showed	  that	  the	  cells	  were	  IDH1	  negatgive.	  The	  proliferation	  rate	  was	  low	  (KI67	  <	  1%).	  The	  nuclei	  
were	  INI1	  positive.	  BRAF	  codon	  analysis	  was	  assessed	  as	  this	  is	  characteristic	  of	  some	  gliofibromas.	  	  
However,	   repeated	   BRAF	   codon	   V600E	   analysis	   showed	   a	   low	   level	   of	   a	   mutation	   (the	  
intraventricular	  biopsy	  was	  negative	  for	  this	  mutation).	  The	  following	  stains	  were	  negative:	  CD34,	  
Desmin,	  NF160	  and	  CAM5.2.	  The	  features	  were	  in	  favour	  of	  a	  gliofibroma.	  The	  histopathology	  of	  
the	   childhood	   right	   lateral	   ventricle	   tumour	   (fig.	   2a)	   showed	   typical	   featrues	   of	   a	   pilocytic	  
astrocytoma	   (WHO	   grade	   I)	   with	   abundant	   Rosenthal	   fibres.	   In	   this	   specimen	   the	   tumour	   cells	  
lacked	  in	  BRAF	  V600E	  mutation	  and	  the	  nuclei	  were	  INI1	  positive.	  
	  
At	  8	  months	  follow-­‐up,	  the	  MRI	  showed	  interval	  progression	  of	  the	  small	  residual	  midbrain	  lesion	  
with	  one	  new	  remote	  tumour	  nodule	   in	  the	  prepontine	  cisterns	  (figs.	  1g-­‐h).	  Further	  surgery	  was	  
not	   feasable,	   and	   stereotactic	   radiosurgery	  was	   considered	   to	  have	   a	  high	   risk	   of	   radionecrosis,	  
especially	   with	   respect	   to	   the	   midbrain	   lesion.	   The	   patient	   was	   treated	   with	   fractionated	  
radiotherapy	   to	   a	   total	   dose	   of	   54Gy	   in	   30	   fractions	   in	   January	   2013.	   Intensity	   modulated	  
radiotherapy	  (IMRT)	  using	  VMAT	  (Volumetric	  Moduated	  Arc	  Therapy,	  RapidArcTM,	  Verion	  Medical	  
Systems,	   Palo	   Alto)	   was	   used	   to	   treat	   the	   five	   nodules	   present	   on	   the	   planning	   MRI,	   with	  
minimisation	   of	   the	   dose	   to	   the	   intervening	   brain,	   with	   the	   maximum	   and	   mean	   dose	   to	   the	  
hypothalamus	  and	  pituitary	  limited	  to	  20.4Gy	  and	  9.8Gy	  respectively.	  At	  last	  follow-­‐up	  in	  October	  
2016	  (42	  months	  post-­‐treatment)	  there	  was	  evidence	  of	  regression	  of	  two	  nodules,	  with	  no	  new	  




Gliofibroma	  was	   first	  decribed	  by	  Friede	  as	  a	   rare	  bimorphic	   tumour	  with	  a	  mixture	  of	  glial	  and	  
fibroblastic	  origins	  [1].	  The	  majority	  are	  supratentorial	  and	  occur	  in	  females	  during	  childhood.	  Our	  
patient	  was	  under	  review	  following	  treatment	  of	  a	  childhood	  pilocytic	  astrocytoma,	  which	  tend	  to	  
have	   a	   favourable	   5	   year	   survival	   rate	   of	   up	   to	   97.3%.	   The	   pilocytic	   astrocytoma	   showed	   no	  
evidence	  of	  local	  recurrence	  for	  6	  years,	  until	  a	  new	  distant	  midbrain	  lesion	  appeared.	  There	  was	  a	  
distinct	   difference	   between	   the	   anatomical	   location	   of	   the	   pilocytic	   astrocytoma	   (right	   lateral	  
ventricle)	  and	  the	  site	  of	  the	  gliofibroma	  within	  the	  midbrain.	  
	  
The	  histogenesis	   of	   gliofibroma	   is	   not	   clearly	  understood	  and	   the	  possible	  hypotheses	   about	   its	  
origin	   have	   not	   been	   confirmed	   [2].	   Thus,	   gliofibroma	   may	   be	   regarded	   as	   a	   member	   of	  
desmoplastic	   astrocytic	   tumours	   within	   a	   spectrum	   of	   malignant	   tumours	   such	   as	   gliosarcoma	  
(WHO	  grade	  IV),	  or	  low-­‐grade	  gliomas	  and	  glioneuronal	  neoplasms	  such	  as	  desmoplastic	  infantile	  
ganglioglioma	  (WHO	  grade	  I)	  and	  non-­‐glial	  tumours	  such	  as	  subtypes	  of	  meningiomas	  and	  solitary	  
fibrous	  tumours.	  However,	  our	  case	  is	  distinct	  from	  these	  entities	  due	  to	  the	  lack	  of	  an	  anaplastic	  
malignant	   component	   or	   neuronal	   differentiation	   with	   the	   above	   immunohistochemical	   profile	  
and	   failed	  detection	  of	   a	  BRAF	  V600E	  mutation.	   	  However,	   it	   should	  be	  noted	   that	  whilst	   BRAF	  
mutation	  is	  considered	  a	  characteristic	  finding	  in	  gliofibroma,	  it	   is	  only	  present	  in	  around	  50%	  of	  
cases.	  
	  
Therefore	  our	  patient	  has	  two	  pathologically	  different	  tumours	  in	  anatomically	  distinct	  locations,	  
and	   importantly	   the	   patient	   had	   not	   received	   any	   prior	   cranial	   irradiation,	   nor	   were	   they	  
syndromic.	   	   There	   was	   no	   familty	   history	   of	   brain	   tumours	   of	   developmental	   abnormalities.	  	  
Several	   gliofibroma	   cases	   have	   been	   reported	   [3],	   but	   none	   associated	  with	   previous	   childhood	  
pilocytic	  astrocytoma.	  It	  is	  possible	  that	  this	  patient	  had	  two	  separate	  unrelated	  glial	  tumours,	  that	  
arose	  sporidically	  or	  as	  a	  results	  of	  environmental	  factors.	  	  The	  absence	  of	  BRAF	  mutations	  in	  both	  
tumours	  supports	  a	  non-­‐genetic	  or	   familial	  cause,	  however	  whole	  genome	  sequencing	  would	  be	  
required	  to	  confirm	  this.	  
	  
The	  optimum	  management	  of	  gliofibroma	  is	  undefined.	  In	  most	  cases,	  the	  prognosis	  is	  favourable,	  
with	   a	   clinical	   course	   without	   recurrence	   or	   metastasis.	   The	   majority	   of	   patients	   do	   not	   have	  
aggressive	  growth	  or	  disease	  progression	  during	  follow	  up.	  The	  first	  line	  treatment	  for	  gliofibroma	  
is	   gross	   total	   surgical	   resection.	   There	   have	   been	   four	   reported	   deaths	   due	   to	   gliofibroma	   in	  
literature	   [1,	   3,	   4],	   however	   the	   follow	   up	   period	   is	   short;	   ranging	   from	   2	  months	   to	   10	   years.	  
Radiotherapy	  has	  been	  used	   in	  four	  cases	  [1,	  4,	  5]	  and	  was	   ineffective	  at	  controlling	  the	  tumour	  
with	   three	   patients	   dead	  within	   18	  months	   of	   treatment.	   However	   in	   our	   patient,	   fractionated	  
radiotherapy	  has	  controlled	  the	  tumour	  for	  3	  years	  with	  no	  evidence	  of	  recurrence	  or	  progression.	  
Due	   to	   the	   rareity	   of	   this	   tumour,	   extended	   follow	   up	   is	   recommended	   in	   order	   to	   better	  
understand	  the	  nature	  and	  long-­‐term	  prognosis	  of	  these	  tumours.	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Axial	   MRI	   imaging	   showing	   the	   appearance	   of	   the	   original	   right	   lateral	   ventricle	   pilocytic	  
astrocytoma	   (a)	   pre-­‐opertive	   T1-­‐weighted	   and;	   (b)	   post-­‐operative	   T1+gadolinium	   confirming	  
complete	  surgical	  resection.	  	  The	  left-­‐sided	  midbrain	  gliofibroma	  is	  shown	  on:	  (c)	  T1-­‐weighted;	  (d)	  
T2-­‐weighted	   and;	   (e)	   T1+gadolinium	   sequences.	   At	   first	   recurrence	   the	   T1+gadolinium	   MRI	  
revealed:	   (f)	   gliofibroma	   at	   the	   midbrain;	   (g)	   pre-­‐pontine	   cistern	   and;	   (h)	   progression	   of	   left	  
midbrain	  gliofibroma.	  
	  Figure	  2	  
(a)	  Histopathological	  features	  of	  the	  pilocytic	  astrocytoma	  of	  the	  right	  lateral	  ventricle	  (H&E);	  (b)	  
Histological	   features	   of	   the	  mid-­‐brain	   biopsy	   specimens	   from	   the	   first	   surgery	   shows	   a	   biphasic	  
tumour	  with	   a	  mainly	   glial	   component	   and	   intermixed	   fibrous	   tissue	   and	   focal	  mature	   fat	   cells	  
(H&E	  ).	   (c)	  At	  second	  surgery	  the	  biopsy	  showed	  a	  biphasic	  neoplasm	  composed	  of	  a	  glial	  and	  a	  
fibrous	   component	   (H&E);	   (d)	   GFAP	   positive	   component	   with	   islands	   of	   glial	   cells	   within	   the	  
stromal	  component;	   (e)	  Higher	   resolution	  showing	   fibriallary	  cells	  admixed	  with	  mature	   fat	   cells	  
(HE);	  (f)	  Isolated	  and	  clusters	  of	  glial	  cells	  expressing	  GFAP	  in	  the	  tumour.	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